REVIEW
Accepted on 15 Jul 2025
Choline alphoscerate: insights between acquired certainties and future perspectives
doi 10.3389/fnagi.2025.1613566
- Frontiers in Pharmacology
- Integrative and Regenerative Pharmacology
- Research Topics
- Challenges and Opportunities with the Rollout of New Alzheimer’s Disease Drugs: A Focus on Non-Alzheimer's Dementia
Challenges and Opportunities with the Rollout of New Alzheimer’s Disease Drugs: A Focus on Non-Alzheimer's Dementia
3,135
Total downloads
13k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 11 Jul 2025
Ramipril and ketogenic diet response in cognitive dysfunction of insulin-resistant rats
doi 10.3389/fphar.2025.1620139
- 302 views
SYSTEMATIC REVIEW
Published on 16 Apr 2025
Re-evaluation of the efficacy and safety of anti-Aβ monoclonal antibodies (lecanemab/donanemab) in the treatment of early Alzheimer’s disease
doi 10.3389/fphar.2025.1599048
- 2,767 views
SYSTEMATIC REVIEW
Published on 22 Aug 2024
Pharmacological treatments for vascular dementia: a systematic review and Bayesian network meta-analysis
doi 10.3389/fphar.2024.1451032
- 5,052 views
- 2 citations
REVIEW
Published on 16 Jul 2024
Herbal medicines in Alzheimer’s disease and the involvement of gut microbiota
doi 10.3389/fphar.2024.1416502
- 2,812 views
- 2 citations
Published in
Frontiers in Pharmacology
Integrative and Regenerative Pharmacology
Neuropharmacology
Participating Journals
Frontiers in Neuroscience
- 3.2 impact factor
- 6.6 citescore